Suscribirse

Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases - 11/08/23

Doi : 10.1016/j.clinre.2023.102170 
Elizabeth T. Jensen a, b, Xiangfeng Dai b, Ellyn Kodroff c, Mary Jo Strobel d, Amy Zicarelli e, Sarah Gray f, Amanda Cordell g, Chelsea Anderson b, Girish Hiremath h, Evan S. Dellon b, i,
a Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA 
b Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA 
c Campaign Urging Research for Eosinophilic Disease (CURED), USA 
d American Partnership for Eosinophilic Disorders (APFED), USA 
e Eosinophilic Family Coalition (EFC), USA 
f AusEE Inc, Australia 
g EOS Network, England 
h Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA 
i Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA 

Corresponding author at: Bioinformatics Building, 130 Mason Farm Rd. UNC-CH, CB#7080, Chapel Hill, NC 27599-7080, USA.Bioinformatics Building130 Mason Farm Rd. UNC-CH, CB#7080Chapel HillNC27599-7080USA

Highlights

Early life exposures have been associated with subsequent development of eosinophilic esophagitis (EoE), but this has not been explored for non-EoE eosinophilic gastrointestinal diseases (EGIDs).
Using a unique online cohort of individuals with and without EGIDs, we observed that certain early life exposures, including certain pregnancy complications, neonatal intensive care unit admission, and antibiotics in infancy, were associated with development of non-EoE EGIDs.
This is the first demonstration of an association between early life risk factors and non-EoE EGIDs and further supports the hypothesis of a shared pathomechanism for disease development across EGIDs.

El texto completo de este artículo está disponible en PDF.

Abstract

Objectives

Early life exposures increase risk of eosinophilic esophagitis (EoE), but it is unknown whether they contribute to increased risk for non-EoE eosinophilic gastrointestinal diseases (EGIDs). We aimed to assess the association between prenatal, antenatal, and early life factors and non-EoE EGIDs.

Methods

We conducted a case-control study based in EGID Partners, an online patient-centered research network. Adults (≥18 years) with non-EoE EGIDs, caregivers of children <18 years of age with an EGID, and non-EGID adult controls were eligible. Subjects completed our Early Life Exposure Questionnaire, detailing maternal and early childhood exposures. We assessed for associations between non-EoE EGIDs and early life exposures, focusing on exposures previously evaluated in association with EoE.

Results

We analyzed 61 non-EoE EGID cases and 20 controls. Of the EGID cases, 14 had eosinophilic gastritis, 19 had eosinophilic enteritis, 6 had eosinophilic colitis, and 22 had multiple areas affected; additionally, 30 had esophageal involvement. Relative to controls, EGID cases were more likely to have had antenatal/perinatal pregnancy-related complications (43% vs 13%; p = 0.02), NICU admission (20% vs 0%; p = 0.03), and antibiotics in infancy (43% vs 10%; p = 0.01). With adjustment for age at diagnosis, we observed increased odds of an EGID for pregnancy complications (aOR 3.83; 95% CI: 0.99–14.9) and antibiotic use in infancy (aOR 7.65; 95% CI: 1.28–45.7).

Conclusions

Early life factors, including pregnancy complications, NICU admission, and antibiotics in infancy, were associated with development of non-EoE EGIDs. The impact of early life exposures on non-EoE EGID pathogenic mechanisms should be investigated.

El texto completo de este artículo está disponible en PDF.

Keywords : Eosinophilic gastrointestinal diseases, Early life exposures, Risk factors, Antibiotics, Neonatal intensive care unit, Pregnancy complications


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 47 - N° 7

Artículo 102170- août 2023 Regresar al número
Artículo precedente Artículo precedente
  • Number of bottles of esophageal biopsies in the evaluation of eosinophilic esophagitis and clinical outcomes
  • Andree H. Koop, John Middleton, Paul M. Travers, Hassan Ghoz, Dawn Francis, Kenneth R. DeVault, Maoyin Pang
| Artículo siguiente Artículo siguiente
  • HMGB1 is related to disease activity in children with celiac disease
  • Murat Yagci, Yusuf Aydemir, Zeren Baris

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.